TITLE

PHARMACOLOGICAL MANIPULATION OF ANGIOTENSIN II AND TRANSFORMING GROWTH FACTOR β-1 IN MESOTHELIAL CELLS

AUTHOR(S)
Goede, A. C.; Sales, K. M.; Khan, K.; Caplin, M. E.; Winslet, M. C.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA64
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study of pharmacological manipulation of angiotensin II and transforming growth factor (TGF) β-1 in mesothelial cells. Desmoplasia, peritoneal fibrosis and adhesion formation as seen in carcinoid tumours involve several cellular and humoral pathways. TGF β-1 is increased at the site of adhesions and in peritoneal effluent from CAPD patients with peritonecil fibrosis. The local renin angiotensin system (RAS) has been shown to modulate TGFβ-1 expression. The aim was to establish if an active local RAS exists in the peritoneum which may regulate TGF β-1 and hence fibrosis.
ACCESSION #
13219063

 

Related Articles

  • Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms. Hong LU; RATERI, Debra L.; BRUEMMER, Dennis; CASSIS, Lisa A.; DAUGHERTY, Alan // Clinical Science;2012, Vol. 123 Issue 9, p531 

    Aortic aneurysms are relatively common maladies that may lead to the devastating consequence of aortic rupture. AAAs (abdominal aortic aneurysms) and TAAs (thoracic aortic aneurysms) are two common forms of aneurysmal diseases in humans that appear to have distinct pathologies and mechanisms....

  • Inhibidores del sistema renina-angiotensina-aldosterona. Diferencias farmacológicas. Méndez-Durán, Antonio // Revista Medica del IMSS;ene/feb2011, Vol. 49 Issue 1, p45 

    No abstract available.

  • Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. Crowley, Steven D.; Gurley, Susan B.; Oliverio, Michael I.; Pazmino, Kathy; Griffiths, Robert; Flannery, Patrick J.; Spurney, Robert F.; Kim, Hyung-Suk; Smithies, Oliver; Le, Thu H.; Coffman, Thomas M.; Pazmino, A Kathy // Journal of Clinical Investigation;Apr2005, Vol. 115 Issue 4, p1092 

    Angiotensin II, acting through type 1 angiotensin (AT(1)) receptors, has potent effects that alter renal excretory mechanisms. Control of sodium excretion by the kidney has been suggested to be the critical mechanism for blood pressure regulation by the renin-angiotensin system (RAS). However,...

  • Modulation of glomerulosclerosis. Ma, Li-Jun; Fogo, Agnes // Seminars in Immunopathology;2007, Vol. 29 Issue 4, p385 

    Regardless of the initial injury, the long-term consequence for the patient depends upon the ensuing balance of profibrotic vs reparative modulators activated. The glomerulus has some capacity for repair. Even when sclerosis has developed with accumulation of extracellular matrix, this lesion...

  • Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats. Obata, Jun-Ei; Nakamura, Takamichi; Kuroyanagi, Rumi; Yoshida, Yoji; Den-Fu Guo; Inagami, Tadashi // Kidney International Supplement;Dec1997, Issue 63, pS229 

    The renin-angiotensin system (RAS) has been implicated in the development of hypertensive glomerulosclerosis. However, there are no experimental findings clearly demonstrating activation of glomerular RAS in hypertensive nephropathy. Using the stroke-prone spontaneously hypertensive rat...

  • Effects of angiotensin II type 1 receptor blockade on transforming growth factor-beta 1 and myocardial remodeling in rats with developing heart failure. Hadyanto, L.; Kasiman, S.; Santoso, T.; Lee, C.N.; Lubis, H.R.; Siregar, Y.; Zhu, Y.Z. // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 1, p159 

    An abstract of the article "Effects of angiotensin II type 1 receptor blockade on transforming growth factor-beta 1 and myocardial remodeling in rats with developing heart failure," by L. Hadyanto and colleagues is presented.

  • TGF-β-mediated activation of RhoA signalling is required for efficient V12HaRas and V600EBRAF transformation. Fleming, Y. M.; Ferguson, G. J.; Spender, L. C.; Larsson, J.; Karlsson, S.; Ozanne, B. W.; Grosse, R.; Inman, G. J. // Oncogene;2/19/2009, Vol. 28 Issue 7, p983 

    Transforming growth factor β-1 (TGF-β) acts as both a tumour suppressor and a tumour promoter in a context-dependent manner. The tumour-promoting activities of TGF-β are likely to result from a combination of Smad and non-Smad signalling pathways but remain poorly understood. Here we...

  • Potential Contribution of Action of Renin Angiotensin System to Bone Metabolism. Nakagami, Hironori; Osako, Mariana Kiomy; Shimizu, Hideo; Hanayama, Rie; Morishita, Ryuichi // Current Hypertension Reviews;2007, Vol. 3 Issue 2, p129 

    Bone metabolism is closely regulated by hormones and cytokines, which have effects on both bone resorption and deposition. Since renin-angiotensin system (RAS) has been known to play an important role to regulate remodeling in several tissues, we focused on the potential role of RAS in bone...

  • The role of locally expressed angiotensin converting enzyme in cardiac remodeling after myocardial infarction in mice. Aartsen, Wendy M.; Schuijt, Martin P.; Danser, A.H. Jan; Daemen, Mat J.A.P.; Smits, Jos F.M. // Cardiovascular Research;Nov2002, Vol. 56 Issue 2, p205 

    Objective: Angiotensin II, generated from angiotensin I by angiotensin converting enzyme (ACE), induces multiple effects including vasoconstriction, positive cardiac inotropy, hypertrophy of cardiomyocytes and proliferation of fibroblasts. ACE exists both in a tissue-bound (t-ACE) and a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics